10-Q

Company

Tempest Therapeutics, Inc.

Filed

August 9, 2018

Period of Report

June 30, 2018

Accession Number

0001544227-18-000007

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →